Literature DB >> 19002754

Large-cell neuroendocrine carcinoma without immunohistological positivity or serum elevation of CEA until relapse.

Yasutaka Watanabe1, Shunsuke Endo, Hiroyoshi Tsubochi, Mitsuhiro Nokubi, Shinichiro Koyama, Yasunori Sohara.   

Abstract

We herein report a case of large cell neuroendocrine carcinoma (LCNEC) originating in the right lung upper lobe and showing unique features at relapse in the right middle lobe. The relapsed tumor pathology included a carcinoembryonic antigen (CEA)-positive mantle component and a CEA-negative core area. The latter showed the same pathological picture as the original tumor, both histologically and immunohistochemically. The serum CEA concentration did not increase until the tumor relapsed, and it fell to within the normal range after resection of the relapsed tumor. Rarely, a newly elevated tumor marker suggests relapse, even in resected cases with a negative immunohistochemical study for the marker.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19002754     DOI: 10.1007/s11748-008-0297-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  10 in total

1.  Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Yasumitsu Moriya; Yuichi Takiguchi; Yasuo Sekine; Kiyoshi Shibuya; Toshihiko Iizasa; Hideki Kimura; Yukio Nakatani; Takehiko Fujisawa
Journal:  Ann Thorac Surg       Date:  2006-11       Impact factor: 4.330

2.  Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.

Authors:  J Slodkowska; M Szturmowicz; P Rudzinski; D Giedronowicz; A Sakowicz; W Androsiuk; E Zakrzewska-Rowinska
Journal:  Eur J Cancer Prev       Date:  1998-02       Impact factor: 2.497

3.  Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.

Authors:  W D Travis; R I Linnoila; M G Tsokos; C L Hitchcock; G B Cutler; L Nieman; G Chrousos; H Pass; J Doppman
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

4.  Sensitivity and specificity of Gold types 1 to 5 anti-carcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues.

Authors:  J M Esteban; R Paxton; P Mehta; H Battifora; J E Shively
Journal:  Hum Pathol       Date:  1993-03       Impact factor: 3.466

5.  Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung.

Authors:  E J Nouwen; D E Pollet; M W Eerdekens; P G Hendrix; T W Briers; M E De Broe
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

6.  Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Tsuyoshi Yuki; Akio Nakagawa; Noriaki Tsubota
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

Review 7.  Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Yukio Nakatani; Takehiko Fujisawa
Journal:  Ann Thorac Surg       Date:  2007-08       Impact factor: 4.330

8.  Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence.

Authors:  Tatsuya Yoshimasu; Yozo Kokawa; Shoji Oura; Issei Hirai; Rie Sasaki; Hirokazu Tanino; Teruhisa Sakurai; Yoshitaka Okamura
Journal:  Cancer Sci       Date:  2003-08       Impact factor: 6.716

9.  Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells.

Authors:  Hiroko Ideo; Akira Seko; Katsuko Yamashita
Journal:  J Biol Chem       Date:  2004-11-16       Impact factor: 5.157

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.